Immix Biopharma (IMMX) Other Gross PP&E Adjustments (2020 - 2026)
Quarterly results put Other Gross PP&E Adjustments at $1.5 million for Q1 2026, up 509.91% from a year ago — trailing twelve months through Mar 2026 was $1.5 million (up 509.91% YoY), and the annual figure for FY2025 was $746601.0, up 181.5%.
Immix Biopharma has reported Other Gross PP&E Adjustments over the past 7 years, most recently at $1.5 million for Q1 2026.
- Other Gross PP&E Adjustments reached $1.5 million in Q1 2026 per IMMX's latest filing, up from $746601.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $1.5 million in Q1 2026 and bottomed at -$1.8 million in Q1 2024.
- Median Other Gross PP&E Adjustments over the past 5 years was -$165572.5 (2022), compared with a mean of -$194298.2.
- The largest annual shift saw Other Gross PP&E Adjustments tumbled 2926.21% in 2024 before it soared 509.91% in 2026.
- Over 5 years, Other Gross PP&E Adjustments stood at -$149599.0 in 2022, then surged by 69.68% to -$45364.0 in 2023, then plummeted by 1919.42% to -$916088.0 in 2024, then surged by 181.5% to $746601.0 in 2025, then surged by 104.74% to $1.5 million in 2026.
- Business Quant data shows Other Gross PP&E Adjustments for IMMX at $1.5 million in Q1 2026, $746601.0 in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 1.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 746,601.00 |
| Dec 31, 2025 | 746,601.00 |
| Sep 30, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | -181,546.00 |
| Jun 30, 2025 | -181,546.00 |
| Mar 31, 2025 | -372,901.00 |
| Mar 31, 2025 | -372,901.00 |
| Dec 31, 2024 | -916,088.00 |
| Dec 31, 2024 | -916,088.00 |
| Sep 30, 2024 | -951,236.00 |
| Sep 30, 2024 | -951,236.00 |
| Jun 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | -1.43 Mn |
| Mar 31, 2024 | -1.82 Mn |
| Mar 31, 2024 | -1.82 Mn |
| Dec 31, 2023 | -45,364.00 |
| Dec 31, 2023 | -45,364.00 |
| Mar 31, 2023 | 64,495.00 |
| Mar 31, 2023 | 64,495.00 |
| Dec 31, 2022 | -149,599.00 |
| Dec 31, 2022 | -149,599.00 |
| Dec 31, 2021 | -105,750.00 |
| Dec 31, 2021 | -105,750.00 |
| Dec 31, 2020 | -43,642.00 |
| Dec 31, 2020 | -43,642.00 |